In patients with COPD, IL-1β is elevated in sputum, serum and bronchoalveolar lavage fluid [4] and, along with IL-1α, is elevated both in patients with stable disease and those experiencing exacerbations [5]. This evidence concerns the gene IL1A and chronic obstructive pulmonary disease.